Cargando…
Immunotherapy for Lung Cancers
Lung cancer is the leading cause of cancer-related deaths worldwide. Although treatment methods in surgery, irradiation, and chemotherapy have improved, prognosis remains unsatisfactory and developing new therapeutic strategies is still an urgent demand. Immunotherapy is a novel therapeutic approach...
Autores principales: | Ho, Ming-Yi, Tang, Shye-Jye, Sun, Kuang-Hui, Yang, Winnie |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035001/ https://www.ncbi.nlm.nih.gov/pubmed/21318107 http://dx.doi.org/10.1155/2011/250860 |
Ejemplares similares
-
Galectin-3 augments tumor initiating property and tumorigenicity of lung cancer through interaction with β-catenin
por: Chung, Ling-Yen, et al.
Publicado: (2014) -
Platinum‐based combination chemotherapy triggers cancer cell death through induction of BNIP3 and ROS, but not autophagy
por: Chung, Ling‐Yen, et al.
Publicado: (2019) -
In Vivo Suppression of Autophagy via Lentiviral shRNA Targeting Atg5 Improves Lupus-Like Syndrome
por: Liu, Chi-Jui, et al.
Publicado: (2020) -
Galectin‐3 promotes CXCR2 to augment the stem‐like property of renal cell carcinoma
por: Huang, Chang‐Shuo, et al.
Publicado: (2018) -
Chimeric 6‐methylsalicylic acid synthase with domains of acyl carrier protein and methyltransferase from Pseudallescheria boydii shows novel biosynthetic activity
por: Liao, Ji‐Long, et al.
Publicado: (2019)